Experimental Investigation of Temperature Influence on Nanoparticle Adhesion in an Artificial Blood Vessel

Abstract

Background A good understanding of the adhesion behaviors of the nanocarriers in microvessels in chemo-hyperthermia synergistic therapy is conducive to nanocarrier design for targeted drug delivery. Methods In this study, we constructed an artificial blood vessel system using gelatins with a complete endothelial monolayer formed on the inner vessel wall. The numbers of adhered NPs under different conditions were measured, as well as the interaction forces between the arginine–glycine–aspartic acid (RGD) ligands and endothelial cells. Results The experimental results on the adhesion of ligand–coated nanoparticles (NPs) with different sizes and morphologies in the blood vessel verified that the gelatin-based artificial vessel possessed good cytocompatibility and mechanical properties, which are suitable for the investigation on NP adhesion characteristics in microvessels. When the temperature deviated from 37 °C, an increase or decrease in temperature resulted in a decrease in the number of adhered NPs, but the margination probability of NP adhesion increased at high temperatures due to the enhanced Brownian movement and flow disturbance. It is found that the effect of cooling was less than that of heating according to the observed changes in cell morphology and a decrease in cell activity under the static and perfusion culture conditions within the temperature range of 25 °C–43 °C. Furthermore, the measurement results of change in the RGD ligand-cell interaction with temperature showed good agreement with those in the number of adhered NPs. Conclusion The Findings suggest that designing ligands that can bind to the receptor and are least susceptible to temperature variation can be an effective means to enhance drug retention.

Review of the Role of Nanotechnology in Overcoming the Challenges Faced in Oral Cancer Diagnosis and Treatment

“…Quantum dots (QDs) are semiconductor nanocrystals that typically have a diameter between 1 and 10 nm and are made up of elements from groups II–IV, IV–VI, or III–V [ 131 ]. QDs have strong fluorescence intensities, narrow emission spectra, broad absorption spectra, and broad excitation spectra from ultraviolet to near-infrared (or between 450 and 850 nm).…”

Development of Biocompatible 3D-Printed Artificial Blood Vessels through Multidimensional Approaches

“…Central to their development are the primary objectives of ensuring long-term patency, characterized by the vessel's sustained openness, and mitigating complications, notably thrombosis, which entails the prevention of blood clot formation. Selecting a suitable bio-ink that supports cell growth, maintains structural integrity during printing, and guarantees post-implantation survival is critical [48,[133][134][135]. The convergence of 3D printing and cellular biology holds a transformative potential for artificial blood vessels.…”

“…This method involves incorporating therapeutic agents or pharmaceutical compounds directly into 3D-printed vascular constructs, offering a unique synergy between structural support and localized drug delivery capabilities. The process begins by selecting a suitable bioink, which acts as a scaffold for the 3D printing process, and loading it with pharmaceutical agents, such as growth factors, anti-inflammatory drugs, or antibiotics [134,135]. Using a 3D bioprinter, the cell-laden bioink is deposited layer-by-layer to construct the desired blood vessel shape while simultaneously embedding the drug-loaded bioink (Figure 2).…”